These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23734707)

  • 21. ΔNp53 and aging.
    Lin SC; Taatjes DJ
    Aging (Albany NY); 2013 Oct; 5(10):717-8. PubMed ID: 24145197
    [No Abstract]   [Full Text] [Related]  

  • 22. Wild-type p53 in cancer cells: when a guardian turns into a blackguard.
    Kim E; Giese A; Deppert W
    Biochem Pharmacol; 2009 Jan; 77(1):11-20. PubMed ID: 18812169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 potentiation of tumor cell susceptibility to CTL involves Fas and mitochondrial pathways.
    Thiery J; Abouzahr S; Dorothee G; Jalil A; Richon C; Vergnon I; Mami-Chouaib F; Chouaib S
    J Immunol; 2005 Jan; 174(2):871-8. PubMed ID: 15634909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artificial regulation of p53 function by modulating its assembly.
    Inobe T; Nozaki M; Nukina N
    Biochem Biophys Res Commun; 2015 Nov; 467(2):322-7. PubMed ID: 26454170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the PI3K-AKT-mTOR signaling pathway promotes DEHP-induced Hep3B cell proliferation.
    Chen X; Qin Q; Zhang W; Zhang Y; Zheng H; Liu C; Yang Y; Xiong W; Yuan J
    Food Chem Toxicol; 2013 Sep; 59():325-33. PubMed ID: 23793038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
    Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
    Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of STAT3/p53 and PI3K-Akt-mTOR signaling pathway on DEHP-induced reproductive toxicity in pubertal male rat.
    Fu G; Dai J; Li Z; Chen F; Liu L; Yi L; Teng Z; Quan C; Zhang L; Zhou T; Donkersley P; Song S; Shi Y
    Toxicol Appl Pharmacol; 2020 Oct; 404():115151. PubMed ID: 32710958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular localization of human p53 expressed in the yeast Saccharomyces cerevisiae: effect of NLSI deletion.
    Abdelmoula-Souissi S; Delahodde A; Bolotin-Fukuhara M; Gargouri A; Mokdad-Gargouri R
    Apoptosis; 2011 Jul; 16(7):746-56. PubMed ID: 21553245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Long Form of CAPON Overexpression on Glioma Cell Proliferation are Dependent on AKT/mTOR/P53 Signaling.
    Liang D; Song Y; Fan G; Ji D; Zhang T; Nie E; Liu X; Liang J; Yu R; Gao S
    Int J Med Sci; 2019; 16(4):614-622. PubMed ID: 31171914
    [No Abstract]   [Full Text] [Related]  

  • 30. Cellular and organismal ageing: Role of the p53 tumor suppressor protein in the induction of transient and terminal senescence.
    Schmid G; Kramer MP; Maurer M; Wandl S; Wesierska-Gadek J
    J Cell Biochem; 2007 Aug; 101(6):1355-69. PubMed ID: 17471501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway.
    Guo Y; Li Y; Wang FF; Xiang B; Huang XO; Ma HB; Gong YP
    Int J Biochem Cell Biol; 2019 Jan; 106():8-20. PubMed ID: 30389549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation.
    Kim J; Yu L; Chen W; Xu Y; Wu M; Todorova D; Tang Q; Feng B; Jiang L; He J; Chen G; Fu X; Xu Y
    Cancer Cell; 2019 Feb; 35(2):191-203.e8. PubMed ID: 30712844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
    Jiang JH; Pi J; Jin H; Cai JY
    J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTOR inactivation in myocardium from infant mice rapidly leads to dilated cardiomyopathy due to translation defects and p53/JNK-mediated apoptosis.
    Mazelin L; Panthu B; Nicot AS; Belotti E; Tintignac L; Teixeira G; Zhang Q; Risson V; Baas D; Delaune E; Derumeaux G; Taillandier D; Ohlmann T; Ovize M; Gangloff YG; Schaeffer L
    J Mol Cell Cardiol; 2016 Aug; 97():213-25. PubMed ID: 27133769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes
    Kong N; Tao W; Ling X; Wang J; Xiao Y; Shi S; Ji X; Shajii A; Gan ST; Kim NY; Duda DG; Xie T; Farokhzad OC; Shi J
    Sci Transl Med; 2019 Dec; 11(523):. PubMed ID: 31852795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutant p53 and mTOR/PKM2 regulation in cancer cells.
    Dando I; Cordani M; Donadelli M
    IUBMB Life; 2016 Sep; 68(9):722-6. PubMed ID: 27385486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas.
    Song K; Li Z; Seth P; Cowan KH; Sinha BK
    Oncol Res; 1997; 9(11-12):603-9. PubMed ID: 9563008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53.
    Hafsi H; Santos-Silva D; Courtois-Cox S; Hainaut P
    BMC Cancer; 2013 Mar; 13():134. PubMed ID: 23514281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cdk2 kinase phosphorylates serine 315 of human p53 in vitro.
    Price BD; Hughes-Davies L; Park SJ
    Oncogene; 1995 Jul; 11(1):73-80. PubMed ID: 7624134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.